Efficacy and prediction analysis of pegylated interferon alpha-2b in treatment-naive HBeAg negative chronic hepatitis B patients with normal ALT: a multicenter real-world study (Ice-breakting Project in China)-Interim analysis

被引：0

作者：

Zhang, Chong ^{[1
]}

Zeng, Da-Wu ^{[2
]}

Cai, Da-Chuan ^{[3
]}

Xue, Xiu-Lan ^{[4
]}

Zhang, Ling-Yi ^{[5
]}

Song, Bao-Jun ^{[6
]}

Gao, Yu-Feng ^{[7
]}

Huang, Yan ^{[8
]}

Shang, Jia ^{[9
]}

Wu, Xiao-Feng ^{[10
]}

Zhang, Ying ^{[11
]}

Jin, Hua ^{[12
]}

Chen, Hui ^{[13
]}

Tang, Hong ^{[14
]}

Lu, Xiaobo ^{[15
]}

Guan, Yujuan ^{[16
]}

Min, Feng ^{[17
]}

Xu, Liang ^{[18
]}

Li, Gang ^{[19
]}

Wang, Zhen-Guang ^{[20
]}

Dou, Xiaoguang ^{[1
]}

机构：

[1] China Med Univ, Shengjing Hosp, Shenyang, Peoples R China

[2] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Peoples R China

[3] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China

[4] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China

[5] Lanzhou Univ, Hosp 2, Lanzhou, Peoples R China

[6] Sixth Peoples Hosp Fushun, Fushun, Peoples R China

[7] Anhui Med Univ, Affiliated Hosp 1, Hefei, Anhui, Peoples R China

[8] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China

[9] Henan Prov Peoples Hosp, Zhengzhou, Henan, Peoples R China

[10] Sixth Peoples Hosp Shenyang, Shenyang, Peoples R China

[11] Dalian Publ Hlth Med Ctr, Dalian, Peoples R China

[12] Sixth Peoples Hosp Benxi, Benxi, Peoples R China

[13] Hepatobiliary Hosp Jilin, Changchun, Jilin, Peoples R China

[14] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China

[15] Xinjiang Med Univ, Affiliated Hosp 1, Urumqi, Peoples R China

[16] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China

[17] Army Seventy Three Army Hosp, Beijing, Peoples R China

[18] Tianjin Second Peoples Hosp, Tianjin, Peoples R China

[19] Liaohe Oilfield Gen Hosp, Panjin, Peoples R China

[20] Anshan City Hosp Infect Dis, Anshan, Peoples R China

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-193

引用

页码：S1165 / S1166

页数：2

共 50 条

[1] Functional cure and prediction analysis of pegylated interferon alpha-2b in HBeAg negative chronic hepatitis B patients with normal ALT (Ice-breaking Project in China): an interim analysis update
Zhang, Chong
Zeng, Dawu
Cai, Dachuan
Xue, Xiulan
Zhang, Lingyi
Song, Baojun
Gao, Yufeng
Huang, Yan
Shang, Jia
Wu, Xiaofeng
Zhang, Ying
Jin, Hua
Chen, Hui
Tang, Hong
Lu, Xiaobo
Guan, Yujuan
Min, Feng
Xu, Liang
Li, Gang
Wang, Zhenguang
Dou, Xiaoguang
JOURNAL OF HEPATOLOGY, 2024, 80 : S803 - S803
[2] Efficacy of Real-world Entecavir Therapy in Treatment-naive Chronic Hepatitis B Patients
Xie, Yan-Di
Ma, Hui
Feng, Ba
Wei, Lai
CHINESE MEDICAL JOURNAL, 2017, 130 (18) : 2190 - 2197
[3] FUNCTIONAL CURE AND PREDICTION ANALYSIS OF PEGYLATED INTERFERON ALPHA2B IN HBEAG NEGATIVE CHRONIC HEPATITIS B PATIENTS WITH NORMAL ALT ( ICE- BREAKING PROJECT IN CHINA): AN INTERIM ANALYSIS UPDATE LITTLE LIVER DISEASE PROGRESSION AFTER LONG- TERM DRUG WITHDRAWAL IN HBEAG POSITIVE POSTPARTUM WOMEN
Zhang, Chong
Zeng, Dawu
Cai, Dachuan
Xue, Xiulan
Zhang, Lingyi
Song, Baojun
Gao, Yufeng
Huang, Yan
Shang, Jia
Wu, Xiaofeng
Zhang, Ying
Jin, Hua
Chen, Hui
Tang, Hong
Lu, Xiaobo
Guan, Yujuan
Min, Feng
Xu, Liang
Li, Gang
Wang, Zhenguang
Dou, Xiaoguang
HEPATOLOGY, 2024, 80 : S224 - S225
[4] Functional cure based on pegylated interferon ? in long-term nucleoside analog suppressed HBeAg negative chronic hepatitis B: a multicenter real-world study (Everest project in China), an interim report
Wu, Ze-Qian
Xie, Dong-Ying
Fu, Lei
Wei, Jia
Shang, Jia
He, Qing
Zhang, Wen-Hua
Huang, Guang-Yu
Peng, Yanzhong
Gu, Ye
Li, Jia-Bin
Guo, Ying
Guan, Yu-Juan
Geng, Jia-Wei
Zheng, Huan-Wei
Gao, Wen-Jun
Zhao, Wen-Jing
Tian, Ying-Jun
Zeng, Yi-Lan
Chen, Ren
Gu, Shengwang
Gao, Zhi-Liang
JOURNAL OF HEPATOLOGY, 2020, 73 : S886 - S887
[5] EFFICACY OF TENOFOVIR ALAFENAMIDE IN TREATMENT NAIVE CHRONIC HEPATITIS B PATIENTS: AN INTERIM ANALYSIS OF 24 WEEKS FROM A REAL-WORLD STUDY
Gan, Weiqiang
Cao, Hong
Xu, Qihuan
Li, Jiangguo
Mai, Li
Chen, Lubiao
Xie, Junqiang
Yang, Lin
Yan, Ying
Zhang, Ka
Li, Gang
HEPATOLOGY, 2020, 72 : 482A - 483A
[6] Peg interferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive patients in Egypt
Elwaki, M. R.
Montasser, M. F.
Mansour, M. A.
Salman, T. A.
El-Batanony, M. H.
Helail, E. H.
Shehata, K. O.
Attallah, K. M.
Madwar, M. A.
LIVER INTERNATIONAL, 2006, 26 : 84 - 84
[7] Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis C: A prospective, multicenter study
Ogawa, Eiichi
Furusyo, Norihiro
Kajiwara, Eiji
Takahashi, Kazuhiro
Nomura, Hideyuki
Maruyama, Toshihiro
Tanabe, Yuichi
Satoh, Takeaki
Nakamuta, Makoto
Kotoh, Kazuhiro
Azuma, Koichi
Dohmen, Kazufumi
Shimoda, Shinji
Hayashi, Jun
JOURNAL OF HEPATOLOGY, 2013, 58 (03) : 495 - 501
[8] Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients
Lee, S. Y.
Lee, S.
Ko, K. S.
Kim, I. H.
Kim, S. H.
Kim, S. W.
Lee, S. O.
Lee, S. T.
Kim, D. G.
Choi, C. S.
Cho, E. Y.
Kim, H. C.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 : A176 - A176
[9] Peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for treatment of chronic hepatitis C in treatment-naive Egyptian patients
El-Wakil, R. M.
Montasser, M. F.
Mansour, M. A.
Salman, T. A.
EL-Batanony, M. H.
Helail, E. H.
Shehata, K. O.
Attallah, K. M.
Madwar, M. A.
JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S142 - S143
[10] A multicenter, randomized, open-label study of peginterferon alpha-2b vs interferon alpha-2b for the treatment of Chinese patients with HBeAg+VE chronic hepatitis B
Zhao, H.
Si, C. -W.
Wei, L.
Wan, M. -B.
Ying, Y. -K.
Hou, J. -L.
Niu, J. -Q.
Wang, G. -Q.
Masashi, M.
JOURNAL OF HEPATOLOGY, 2006, 44 : S20 - S21

← 1 2 3 4 5 →